IO BIOTECH INC's ticker is and the CUSIP is 449778109. A total of 22 filers reported holding IO BIOTECH INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $37 | -21.3% | 19,917 | -3.1% | 0.00% | – |
| Q4 2022 | $47 | -100.0% | 20,554 | -46.4% | 0.00% | – |
| Q3 2022 | $104,000 | -51.9% | 38,322 | -17.1% | 0.00% | – |
| Q2 2022 | $216,000 | -43.9% | 46,231 | -36.4% | 0.00% | – |
| Q1 2022 | $385,000 | -24.8% | 72,728 | -6.7% | 0.00% | – |
| Q4 2021 | $512,000 | – | 77,963 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,120,437 | $7,171,000 | 1.39% |
| Vivo Capital, LLC | 3,015,545 | $19,299,000 | 1.16% |
| Novo Holdings A/S | 3,277,932 | $20,979,000 | 0.99% |
| Soleus Capital Management, L.P. | 672,734 | $4,305,000 | 0.43% |
| PFM Health Sciences, LP | 1,362,144 | $7,744,000 | 0.26% |
| RA Capital Management | 1,857,755 | $11,890,000 | 0.21% |
| Avoro Capital Advisors LLC | 2,055,883 | $10,243,000 | 0.17% |
| Virtu Financial LLC | 12,665 | $83,000 | 0.01% |
| CAAS CAPITAL MANAGEMENT LP | 50,479 | $323,000 | 0.01% |
| Capital World Investors | 1,235,000 | $8,114,000 | 0.00% |